[HTML] cell.com

[HTML][HTML] A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques

RR Cobb, J Nkolola, P Gilchuk, A Chandrashekar, J Yu… - Med, 2022 - cell.com
Background Human monoclonal antibody (mAb) treatments are promising for COVID-19
prevention or therapy. The pre-exposure prophylactic efficacy of neutralizing antibodies that …
被引用次数：15 相关文章
[HTML] sciencedirect.com

[HTML][HTML] A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques

RR Cobb, J Nkolola, P Gilchuk, A Chandrashekar, J Yu… - Med, 2022 - Elsevier
Background Human monoclonal antibody (mAb) treatments are promising for COVID-19
prevention or therapy. The pre-exposure prophylactic efficacy of neutralizing antibodies that …

A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques.

RR Cobb, J Nkolola, P Gilchuk… - Med (New York …, 2022 - europepmc.org
Background Human monoclonal antibody (mAb) treatments are promising for COVID-19
prevention or therapy. The pre-exposure prophylactic efficacy of neutralizing antibodies that …

A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques

RR Cobb, J Nkolola, P Gilchuk… - Med (New York …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Human monoclonal antibody (mAb) treatments are promising for COVID-19
prevention or therapy. The pre-exposure prophylactic efficacy of neutralizing antibodies that …

A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques

RR Cobb, J Nkolola, P Gilchuk, A Chandrashekar, J Yu… - Med, 2022 - profiles.wustl.edu
Background: Human monoclonal antibody (mAb) treatments are promising for COVID-19
prevention or therapy. The pre-exposure prophylactic efficacy of neutralizing antibodies that …
[HTML] nih.gov

[HTML][HTML] A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques

RR Cobb, J Nkolola, P Gilchuk… - Med (New York …, 2022 - ncbi.nlm.nih.gov
Background Human monoclonal antibody (mAb) treatments are promising for COVID-19
prevention or therapy. The pre-exposure prophylactic efficacy of neutralizing antibodies that …